Immunomodulatory effects of the intake of fermented milk with Lactobacillus casei DN114001 in lactating mothers and their children

British Journal of Nutrition

Volumn 100, Issue 4, 2008, Pages 834-845

  Ortiz Andrellucchi, Adriana ^a   Sánchez Villegas, Almudena ^a   Rodríguez Gallego, Carlos ^b   Lemes, Angelina ^b   Molero, Teresa ^b   Soria, Adela ^c   Peña Quintana, Luis ^a,d   Santana, Milagrosa ^d   Ramírez, Octavio ^d   García, José ^d   Cabrera, Félix ^a   Cobo, José ^e   Serra Majem, Lluís ^a  

^a UNIVERSITY OF LAS PALMAS DE GRAN CANARIA   (Spain)

^b HOSPITAL UNIVERSITARIO DE GRAN CANARIA DR NEGRÍN   (Spain)

^c HOSPITAL UNIVERSITARIO INSULAR DE GRAN CANARIA   (Spain)

^d Hospital Universitario Materno Infantil de Canarias   (Spain)

^e Danone S A   (Spain)

Author keywords

Clinical trials; Cytokines; Human milk; Immune response; Lactobacillus casei DN114001; Postpartum period; Probiotics

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 4; PLACEBO; PROBIOTIC AGENT; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ALLERGY; ANTHROPOMETRY; ARTICLE; B LYMPHOCYTE; BACTERIAL STRAIN; CLINICAL TRIAL; COLOSTRUM; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTOMETRY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG MECHANISM; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FERMENTATION; FLOW CYTOMETRY; FOLLOW UP; GASTROINTESTINAL SYMPTOM; HUMAN; HUMAN CELL; IMMUNOMODULATION; INFANT; LACTATION; LACTOBACILLUS CASEI; MAJOR CLINICAL STUDY; MATERNAL NUTRITION; MILK; NATURAL KILLER CELL; NEWBORN; NEWBORN INFECTION; OUTCOME ASSESSMENT; PUERPERIUM; RANDOMIZED CONTROLLED TRIAL; SAMPLE SIZE; T LYMPHOCYTE; TH1 CELL; TH2 CELL;

ADOLESCENT; ADULT; B-LYMPHOCYTES; BREAST FEEDING; CHI-SQUARE DISTRIBUTION; CULTURED MILK PRODUCTS; CYTOKINES; DIETARY SUPPLEMENTS; DOUBLE-BLIND METHOD; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERSENSITIVITY; INFANT, NEWBORN; INTERLEUKIN-10; KILLER CELLS, NATURAL; LACTOBACILLUS CASEI; LYMPHOCYTE COUNT; MILK, HUMAN; MOTHERS; POSTPARTUM PERIOD; PROBIOTICS; PROSPECTIVE STUDIES; TH1 CELLS; TH2 CELLS; TUMOR NECROSIS FACTOR-ALPHA; YOUNG ADULT;

LACTOBACILLUS CASEI;

EID: 51749108011     PISSN: 00071145     EISSN: 14752662     Source Type: Journal    
DOI: 10.1017/S0007114508959183     Document Type: Article

References (47)

1. Aagaard-Tillery KM, Silver R & Dalton J (2006) Immunology of normal pregnancy. Semin Fetal Neonatal Med 11, 279-295.
2. Makhseed M, Raghupathy R, Azizieh F, Omu A, Al-Shamali E & Ashkanani L (2001) Th1 and Th2 cytokine profiles in recurrent aborters with successful pregnancy and with subsequent abortions. Hum Reprod 16, 2219-2226.
3. Kruse N, Greif M, Moriabadi NF, Marx L, Toyka KV & Rieckmann P (2000) Variations in cytokine mRNA expression during normal human pregnancy. Clin Exp Immunol 119, 317-322.
4. Reinhard G, Noll A, Schlebusch H, Mallmann P & Ruecker AV (1998) Shifts in the Th1/Th2 balance during human pregnancy correlate with apoptotic changes. Biochem Biophys Res Comm 245, 933-938.
5. Hill JA, Polgar K & Anderson DJ (1995) T-helper 1-type immunity to trophoblast in women with recurrent spontaneous abortion. JAMA 273, 1933-1936.
6. Raghupathy R, Makhseed M, Azizieh E, Hassan N, Al-Azemi M & Al-Shamali E (1999) Maternal Th1 and Th2-type reactivity to placental antigens in normal human pregnancy and unexplained recurrent spontaneous abortions. Cell Immunol 196, 122-130.
7. Chaouat G, Menu E, Clark DA, Dy M, Minkowski M & Wegmann TG (1990) Control of fetal survival in CBA × DBA/2 mice by lymphokine therapy. J Reprod Fertil 89, 447-457.
8. Wilder RL (1998) Hormones, pregnancy, and autoinumme diseases. Ann N Y Acad Sci 80, 45-50.
9. +) percentages and semin immunoglobulin concentrations correlate with breast-feeding behavior and serum prolactin concentration. Am J Reprod Immunol 40, 57-62.
10. +) percents during the first 8 months post-partum. J Reprod Immunol 30, 81-95.
11. +) cells: correlations with iron status, parity, supplement use, and lactation status. Am J Clin Nutr 67, 897-904.
12. Salminen SJ, Gueimonde M & Isolauri E (2005) Probiotics that modify disease risk. J Nutr 135, 1294-1298.
13. Erickson KL & Hubbard NE (2000) Probiotic immunomodulation in health and disease. J Nutr 130, Suppl. 2, S403-S409.
14. O'Sullivan GC, Kelly P, O'Halloran S, Collins, C, Collins JY, Dunne C & Shanahan F (2005) Probiotics: An emerging therapy. Curr Pharm Des 11, 3-10.
15. Perdigon G, Fuller R & Raya R (2001) Lactic acid bacteria and their effect on the immune system. Curr Issues Intest Microbiol 2, 27-42.
16. Isolauri E, Sutas Y, Kankaanpaa P, Arvilommi H & Salminen S (2001) Probiotics: Effects on immunity. Am J Clin Nutr 73, Suppl. 2, S444-S450.
17. Lopez-Varela. S, Gonzalez-Gross M & Marcos A (2002) Functional foods and the immune system: A review. Eur J Clin Nutr 56, Suppl. 3, S29-S33.
18. Maassen CB, van Holten-Neelen C, Balk F, den Bak-Glashouwer MJ, Leer RJ, Laman JD, Boersma WJ & Claassen E (2000) Strain-dependent induction of cytokine profiles in the gut by orally administered Lactobacillus strain. Vaccine 18, 2613-2623.
19. Spanhaak S, Havenaar R & Schaafsma G (1998) The effect of consumption of milk fermented by Lactabacillus casei strain Shirota on the intestinal microflora and immune parameters in human. Eur J Clin Nutr 52, 899-907.
20. Matsuzaki T (1998) Immunomodulation by treatment with Lactobacillus casei strain Shirota. Int J Food Microbiol 41, 133-140.
21. Kato I, Tanaka K & Yokokura T (1999) Lactic acid bacterium potently induces the production of interleukin-12 and interferon-γ by mouse splenocytes. Int J Immunopharmacol 21, 121-131.
22. Hori T, Kiyoshima J, Shida K & Yasui H (2002) Augmentation of cellular immunity and reduction of influenza virus titer in aged mice fed Lactobacillus casei strain Shirota. Clin Diagn Lab Immunol 9 105-108.
23. Bautista-Garfias CR, Ixta-Rodriguez O, Martínez-Gómez F, López MG & Aguilar-Figueroa BR (2001) Effect of viable or dead Lactobacillus casei organisms administered orally to mice on resistance against Trichinella spiralis infection. Parasite 8, Suppl. 2, S226-S228.
24. Nagao F, Nakayama M, Muto T & Okumura K (2000) Effects of a fermented milk drink containing Lactobacillus casei strain Shirota on the immune system in healthy human subjects. Biosci Biotechnol Biochem 64, 2706-2708.
25. Rigotti E, Piacentini GL, Ress M, Pigozzi R, Boner AL & Peroni DG (2006) Transforming growth factor-ß and interleukin-10 in breast milk and delopment of atopic diseases in infants. Clin Exp Allergy 36 614-618.
26. Marcos A, Warnberg J, Nova E, Gomez S, Alvarez A, Alvarez R, Mateos JA & Cobo JM (2004) The effect of milk fermented by yogurt cultures plus Lactobacillus casei DN-114001 on the immune response of subjects under academic examination stress. Eur J Nutr 43, 381-389.
27. Bendelac A, Savage PB & Teyton L (2007) The biology of NKT cells. Annu Rev Immunol 25, 297-336.
28. Pearson H (2002) Reproductive immunology: Immunity's pregnant pause. Nature 420, 265-266.
29. Gustafsson C, Hummerdal P, Matthiesen L, Berg G, Ekerfelt C & Ernerudh J (2006) Cytokine secretion in decidual mononuclear cells from term human pregnancy with or without labour: ELISPOT detection of IFN-γ, EL-4, IL-10, TGF-β and TNF-α. J Reprod Immunol 71, 41-56.
30. Shimaoka. Y, Hidaka Y, Tada H, Nakamura T, Mitsuda N, Morimoto Y, Murata Y & Amino N (2000) Changes in cytokine production during and after normal pregnancy. Am J Reprod Immunol 44, 143-147.
31. Matsuzaki T & Chin J (2000) Modulating immune responses with probiotic bacteria. Immunol Cell Biol 78, 67-73.
32. Fang H, Elina T, Heikki A & Seppo S (2000) Modulation of humoral immune response through probiotic intake. FEMS Immunol Med Microbiol 29, 47-52.
33. Rinne M, Kalliomaki M, Arvilommi H, Salminen S & Lsolauri E (2005), Effect of probiotics and breastfeeding on the bifidobacterim and lactobacillus/enterococcus microbiota and humoral immune responses. J Pediatr 147, 186-191.
34. Faria AM & Weiner HL (2006) Oral tolerance: Therapeutic implications for autoimmune diseases. Clin Dev Immunol 13, 143-157.
35. Boucher MF, Jebnalm MC, Garofalo RP & Bjorksten B (2000) Cytokines in breast milk form allergic and nonallergic mothers. Pediatr Res 47, 157-162.
36. Oddy WK Halonen M, Martinez FD, Lohman IC, Stern DA, Kurzius-Spencer M, Guerra S & Wright AL (2003) TGF-β in human milk is associated with wheeze in infancy. J Allergy Clin Immunol 112, 723-728.
37. Bottcher W, Jenmalm MC & Bjorkstén B (2003) Cytokine, chemokine, and secretory IgA levels in human milk in relation to atopic disease and IgA production in infants. Pediatr Allergy Immunol 14, 35-41.
38. Rautava S, Kalliomaki M & Isolauri E (2002) Probiotics during pregnancy and breast-feeding might confer immunomodulatory protection against atopic disease in the infant. J Allergy Clin Immunol 109, 119-121.
39. Borruel N, Carol M, Casellas F, Antolin M, de Lara F, Espin E, Naval J, Guarner F & Malagelada JR (2002) Increased mucosal tumour necrosis factor α production in Crohn's disease can be downregulated ex vivo by probiotic: Bacteria. Gut 51, 659-664.
40. Takahata Y, Takada H, Nomura A, Ohshima & Nakayama H, Tsuda, T, Nakano H & Hara T (2001) Interleukin-18 in human milk. Pediatr Res 50 268-272.
41. Hawkes JS, Bryan DL, James MJ & Gibson RA (1999) Cytokines, (IL-1β, EL-6, TNF-α, TGF-β1, and TGF-β2) and prostaglandin E2 in human milk during the first three months postpartum. Pediatr Res 46, 194-199.
42. Isolauri F, Arvola T, Sutas Y, Moilanen E & Salminen S (2000) Probiotics in the management of atopic: Eczema. Clin Exp Allergy 30, 1604-1610.
43. Mastretta, E, Longo P, Laccisaglia A, Balbo L, Russo P4 Mazzaccara A & Gianino P (2002) Effect of Lactobacillus GG and breast-feeding in the prevention of rotavirus nosocomial infection. J Pediatr Gastroenterol Nutr 35, 527-531.
44. Lin HC, Su BH, Chen AC, Lin TW, Tsai CK Yeh TF & Oh W (2005) Oral probiotics reduce the incidence and severity of necrotizing enterocolitis in very low birth weight infants. Pediatrics 115 1-4.
45. Schultz M, Gottl C, Young RJ, Iwen P & Vanderhoof JA (2004) Administration of oral probiotic bacteria to pregnant women causes temporary infantile colonization. J Pediatr Gavroenterol Nutr 39, 293-297.
46. Shakhar K, Rosenne E, Loewenthal P, Shakhar G & Carp H (2006) High NK cell activity in recurrent miscarriage: What are we really measuring? Hum Reprod 21, 2421-2425.
47. Shakhar K, & Ben-Eliyahu S, Loewenthal & Rosenne E & Carp H (2003) Differences in number and activity of peripheral natural killer cells in primary versus secondary recurrent miscarriage. Fertil Steril 80, 368-375.